OptiBiotix Health PLC (OPTI)

Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

14.75p

Buy

15.25p

arrow-up0.10p (+0.67%)

Prices updated at 28 May 2025, 09:45 BST
| Prices minimum 15 mins delay
|
Prices in GBX
OptiBiotix Health PLC is a life sciences company. The company through its subsidiaries is engaged in the research and development of microbiome modulators.
FTSE All-Share
arrow-down-0.02%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Biotechnology
Chairman
Mr. Richard Colin Neil Davidson CBE
CEO
Mr. Stephen Patrick O'Hara
Most recent earnings
31 Dec 2023
Fiscal year end
31 Dec 2023
Employees
5
Head office
Innovation Centre, Innovation Way
York
United Kingdom
YO10 5DG
mobile
+44 1904435100
letter
info@optibiotix.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Mr. Richard Colin Neil Davidson CBE
Non-Executive Director, Chairman
-
Mr. Michael Sean Christie
Non-Executive Director
-
Dr. Sofia Kolyda
Executive Director, Research and Development
-
Mr. Stephen Patrick O'Hara
Executive Director, Chief Executive Officer
-

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
No data

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
No data
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.